I implacably disagree that it is only "a small part of management's job to look after existing shareholders" It is their raison d'etre.
In my view the reasons given to allow "Soph Investors " a lesser price than us is double speak. Why not allow existing shareholders more shares?
- Forums
- ASX - By Stock
- SLX
- Ann: Trading Halt
Ann: Trading Halt, page-33
-
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.17 |
Change
-0.010(0.19%) |
Mkt cap ! $1.224B |
Open | High | Low | Value | Volume |
$5.18 | $5.20 | $5.10 | $1.179M | 229.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1277 | $5.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.17 | 1821 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1277 | 5.130 |
2 | 7136 | 5.120 |
1 | 1277 | 5.110 |
1 | 1277 | 5.100 |
1 | 5000 | 5.090 |
Price($) | Vol. | No. |
---|---|---|
5.170 | 1821 | 1 |
5.190 | 3115 | 2 |
5.200 | 1277 | 1 |
5.210 | 1277 | 1 |
5.220 | 2277 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
SLX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online